XML 70 R51.htm IDEA: XBRL DOCUMENT v3.25.0.1
Vibativ®, Sancuso® and RediTrex® Products - Narrative (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jul. 12, 2022
Jan. 03, 2022
Nov. 27, 2019
Oct. 31, 2023
Jan. 31, 2023
Apr. 30, 2019
Nov. 30, 2018
Nov. 30, 2016
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2020
Jul. 31, 2020
Business Acquisition [Line Items]                        
Non-current portion of accrued contingent consideration                 $ 2,877,312 $ 3,284,672    
Goodwill                 914,000 $ 914,000    
Nordic Group B.V. | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Milestone payment $ 1,000,000                      
Milestone payment credit due $ 1,000,000                      
Nordic Group B.V. | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Restricted Stock                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Shares cancelled and refunded 180,000                      
Nordic Group B.V. | Methotrexate | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Deposit payment               $ 100,000        
Share consideration, value               $ 900,000        
Share consideration vested, value     $ 900,000                  
Milestone payment                     $ 1,000,000 $ 1,000,000
Nordic Group B.V. | Methotrexate | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Restricted Stock                        
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                        
Share consideration (in shares)               180,000        
Product Assets And Global Rights - Vibativ                        
Business Acquisition [Line Items]                        
Payment to acquire business upon closing             $ 20,000,000          
MIlestone payment           $ 5,000,000            
Tiered royalty payments, threshold             $ 2,500,000          
Studies accrual                 1,100,000      
Non-current portion of accrued contingent consideration                 2,100,000      
Product Assets And Global Rights - Vibativ | Maximum                        
Business Acquisition [Line Items]                        
Tiered royalty payments (percentage)             20.00%          
U.S. Product Asset Rights - Sancuso                        
Business Acquisition [Line Items]                        
Payment to acquire business upon closing   $ 13,500,000                    
MIlestone payment       $ 500,000 $ 1,000,000              
Tiered royalty payments, threshold   3,500,000                    
Studies accrual                 800,000      
Non-current portion of accrued contingent consideration                 700,000      
Milestone payment remaining                 $ 2,000,000      
Contingent liability   3,400,000                    
Prepaid expense and other assets   1,800,000                    
Inventory   2,600,000                    
Goodwill   30,000.00                    
Intangible assets, other than goodwill   14,100,000                    
Milestone payable   $ 1,700,000                    
U.S. Product Asset Rights - Sancuso | Maximum                        
Business Acquisition [Line Items]                        
Tiered royalty payments (percentage)   10.00%